CLINICAL_TRIALS
trial_result
· 2026-01-09
Clinical Trial Update: Estrogen and Fear in PTSD [Phase 3]
Summary
Phase 3 trial evaluating estrogen treatment for fear modulation in post-traumatic stress disorder has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: The University of Texas Health Science Center, Houston | Conditions: PTSD | Phase 3 | Status: COMPLETED | Results posted: 2026-01-09